Development of a Novel Prognostic Score for Intrahepatic Cholangiocarcinoma Based on Tumor Size and Number of Tumor
Outcomes of Patients Receiving Lenvatinib or Atezolizumab Plus Bevacizumab as First-line Treatment for Unresectable Hepatocellular Carcinoma: PRISM Study
Cancer Neutrophil Encyclopedia: A Deep Dive into Antigen-Presenting Warriors
Genomic landscape of clinically actionable FGFR alterations in biliary tract cancer and across solid tumors